EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Proteomic Analysis Identifies Association of Periostin, a Matricellular Protein, with High Tumor Stroma and Immune Exclusion in Triple-Negative Breast Cancer

Yeonjin Jeon, GunHee Lee, Byung-Kwan Jeong, Yoon Young Kim, JiSun Kim, Jae Ho Jeong, Kyunggon Kim, Hee Jin Lee

Cancer Research and Treatment · 15.07.2026 · 58 (3) · 748-769

DOI: 10.4143/crt.2025.145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Research and Treatment, erschienen am 15.07.2026. Verfasst von Yeonjin Jeon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Periostin, Triple Negative Breast Neoplasms, Proteomics, Biomarkers, Tumor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Asan Institute for Life Sciences, Asan Medical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Immune-excluded/desert tumors show reduced responsiveness to immunotherapy compared to inflamed tumors. The tumor stroma contributes to immune evasion. This study aimed to identify proteins overexpressed in tumors with high tumor stroma among immune excluded triple-negative breast cancer (TNBC) to better understand the mechanisms of immune exclusion.Materials and Methods Proteomic analysis was conducted on formalin-fixed, paraffin-embedded samples from 403 cases of TNBC. We compared protein expression between stroma-high versus stroma-low within the immune-excluded subtype. We investigated the correlations between the identified protein expression and other clinicopathologic features. Immunohistochemical (IHC) staining and single-cell analysis were conducted, along with survival analysis.

Results

Among the 247 eligible cases, 81 (32.8%) were classified as immune-excluded and 166 (67.2%) as inflamed. Within the excluded subtype, periostin was the only extracellular matrix-related protein significantly overexpressed in stroma-high cases. Periostin expression demonstrated a positive correlation with the amount of stroma (r=0.51, p < 0.001) and a negative correlation with tumor-infiltrating lymphocytes (TILs) (r=−0.30, p < 0.001). Periostin expression in the tumor stroma was confirmed by IHC. Single-cell analysis demonstrated that periostin originated from cancer-associated fibroblasts (CAFs). High periostin levels correlated with poorer recurrence-free survival (hazard ratio, 1.422; p=0.005).

Conclusion

Periostin is overexpressed in stroma-rich, immune-excluded TNBC and is derived from CAFs. Its expression is associated with reduced TILs and poor prognosis. The development of targeted agents against periostin-positive CAFs may help overcome immune evasion and improve the effectiveness of immunotherapy in TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeriostinTriple Negative Breast NeoplasmsProteomicsBiomarkers, TumorCell Adhesion MoleculesHumansFemaleMiddle AgedPrognosisLymphocytes, Tumor-InfiltratingTumor MicroenvironmentAdultStromal CellsAged

Stichwörter der Autor:innen

Immune subtypesPeriostinProteomic analysisTriple-negative breast neoplasmsTumor stroma

Substanzen

PeriostinPOSTN protein, humanBiomarkers, TumorCell Adhesion Molecules

Autor:innen und Institutionen

  • Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Department of Diagnostic Pathology, Samkwang Medical Laboratories, Seoul, Korea.
  • Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Department of Digital Medicine, University of Ulsan College of Medicine, Seoul, Korea. kimkyunggon@gmail.com.
  • Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. backlila@gmail.com.

Förderung

  • Asan Institute for Life Sciences, Asan Medical Center

Zitieren

APA

Jeon, Y., Lee, G., Jeong, B. K., Kim, Y. Y., Kim, J., Jeong, J. H., Kim, K., & Lee, H. J. (2026). Proteomic Analysis Identifies Association of Periostin, a Matricellular Protein, with High Tumor Stroma and Immune Exclusion in Triple-Negative Breast Cancer. Cancer Research and Treatment, 58(3), 748-769. https://doi.org/10.4143/crt.2025.145

Vancouver

Jeon Y, Lee G, Jeong BK, Kim YY, Kim J, Jeong JH, et al. Proteomic Analysis Identifies Association of Periostin, a Matricellular Protein, with High Tumor Stroma and Immune Exclusion in Triple-Negative Breast Cancer. Cancer Research and Treatment. 2026;58(3):748-769. doi:10.4143/crt.2025.145

BibTeX
@article{Jeon2026,
  author = {Jeon, Yeonjin and Lee, GunHee and Jeong, Byung-Kwan and Kim, Yoon Young and Kim, JiSun and Jeong, Jae Ho and Kim, Kyunggon and Lee, Hee Jin},
  title = {Proteomic Analysis Identifies Association of Periostin, a Matricellular Protein, with High Tumor Stroma and Immune Exclusion in Triple-Negative Breast Cancer},
  journal = {Cancer Research and Treatment},
  year = {2026},
  volume = {58},
  number = {3},
  pages = {748--769},
  doi = {10.4143/crt.2025.145}
}
Kostenlos starten →